BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sachdeva S, Joo H, Tsai J, Jasti B, Li X. A Rational Approach for Creating Peptides Mimicking Antibody Binding. Sci Rep 2019;9:997. [PMID: 30700733 DOI: 10.1038/s41598-018-37201-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Debnath U, Verma S, Patra J, Mandal SK. A review on recent synthetic routes and computational approaches for antibody drug conjugation developments used in anti-cancer therapy. Journal of Molecular Structure 2022;1256:132524. [DOI: 10.1016/j.molstruc.2022.132524] [Reference Citation Analysis]
2 Yang F, Liu L, Neuenschwander PF, Idell S, Vankayalapati R, Jain KG, Du K, Ji H, Yi G. Phage Display-Derived Peptide for the Specific Binding of SARS-CoV-2. ACS Omega 2022;7:3203-11. [PMID: 35128233 DOI: 10.1021/acsomega.1c04873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kim SH, Lee EH, Kim HJ, Kim AR, Kim YE, Lee JH, Yoon MY, Koh SH. Development of a Low-Molecular-Weight Aβ42 Detection System Using a Enzyme-Linked Peptide Assay. Biomolecules 2021;11:1818. [PMID: 34944462 DOI: 10.3390/biom11121818] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Iranpour S, Bahrami AR, Sh. Saljooghi A, Matin MM. Application of smart nanoparticles as a potential platform for effective colorectal cancer therapy. Coordination Chemistry Reviews 2021;442:213949. [DOI: 10.1016/j.ccr.2021.213949] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
5 Zhou J, Li Y, Huang W, Shi W, Qian H. Source and exploration of the peptides used to construct peptide-drug conjugates. Eur J Med Chem 2021;224:113712. [PMID: 34303870 DOI: 10.1016/j.ejmech.2021.113712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Teng KW, Tsai ST, Hattori T, Fedele C, Koide A, Yang C, Hou X, Zhang Y, Neel BG, O'Bryan JP, Koide S. Selective and noncovalent targeting of RAS mutants for inhibition and degradation. Nat Commun 2021;12:2656. [PMID: 33976200 DOI: 10.1038/s41467-021-22969-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
7 Mathew S, Taleb S, Eid AH, Althani AA, Yassine HM. In silico virtual screening of lead compounds for major antigenic sites in respiratory syncytial virus fusion protein. Emergent Mater 2021;:1-11. [PMID: 33969268 DOI: 10.1007/s42247-021-00213-6] [Reference Citation Analysis]
8 Sun M, Miyazawa K, Pendekanti T, Razmi A, Firlar E, Yang S, Shokuhfar T, Li O, Li W, Sen Gupta A. Combination targeting of 'platelets + fibrin' enhances clot anchorage efficiency of nanoparticles for vascular drug delivery. Nanoscale 2020;12:21255-70. [PMID: 33063812 DOI: 10.1039/d0nr03633a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Martinez de la Torre C, Grossman JH, Bobko AA, Bennewitz MF. Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time. PLoS One 2020;15:e0239034. [PMID: 32946514 DOI: 10.1371/journal.pone.0239034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Kim SH, Lee EH, Lee SC, Kim AR, Park HH, Son JW, Koh SH, Yoon MY. Development of peptide aptamers as alternatives for antibody in the detection of amyloid-beta 42 aggregates. Anal Biochem 2020;609:113921. [PMID: 32828793 DOI: 10.1016/j.ab.2020.113921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ueno S, Kim MW, Lee G, Park YI, Niidome T, Lee R. Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer. Pharmaceutics 2020;12:E585. [PMID: 32599712 DOI: 10.3390/pharmaceutics12060585] [Reference Citation Analysis]
12 Pethő L, Kasza G, Lajkó E, Láng O, Kőhidai L, Iván B, Mező G. Amphiphilic drug–peptide–polymer conjugates based on poly(ethylene glycol) and hyperbranched polyglycerol for epidermal growth factor receptor targeting: the effect of conjugate aggregation on in vitro activity. Soft Matter 2020;16:5759-69. [DOI: 10.1039/d0sm00428f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]